Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Orchard Therapeutics Q2 EPS $(0.04) Up From $(0.29) YoY

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.
byBenzinga Newsdesk
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.04) per share. This is a 86.21 percent increase over losses of $(0.29) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Biden Targets Chinese Imports With Huge Tariff Hikes Ahead of Election

By Shivani Kumaresan
May 14, 7:43 AM
The Biden administration unveils targeted tariffs on Chinese goods, including electric vehicles and semiconductors, to safeguard American jobs. Lael Brainard stresses the move's necessity to counter China's unfair trade practices and bolster domestic industries. With tariffs affecting $18 billion worth of imports, strategic sectors like aluminum, steel, and critical minerals are prioritized, aligning with key legislative goals.

AA